Allergan plc announced it will establish an R&D presence in the Kendall Square section of Cambridge, Massachusetts, a hub of science, innovation and business opportunities.

The site will be led by Don Frail, PhD, Senior Vice President of Research and External Scientific Innovation (RESI) and Non-Clinical and Translational Sciences. Dr. Frail joined Allergan in 2014, relocating from Boston to the Allergan R&D center in Irvine, CA, and has led the Research, Clinical Pharmacology, Toxicology and ADME departments including the External Science & Innovation initiatives to evaluate and implement partnerships and acquisitions across Allergan's four key therapeutic areas. Don will continue to lead the Irvine team as well.